Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
15.66
-0.12 (-0.76%)
At close: Nov 13, 2026, 4:00 PM EST
15.10
-0.56 (-3.58%)
After-hours: Nov 13, 2026, 7:42 PM EST
Erasca Market Cap
Erasca has a market cap or net worth of $5.5 billion as of November 13, 2026. It is the 3,341st most valuable company in the world and the 1,087th biggest in the United States. Its market cap has increased by 631.01% in one year.
Market Cap
5.50B
Enterprise Value
4.59B
1-Year Change
631.01%
Global Rank
Country Rank
#1,087 United States
Category
ChartMarket Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $5.50B, an increase of 195.75%. That is a compound annual growth rate of 22.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 5.50B | 420.74% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 6.40B |
| Ligand Pharmaceuticals | 6.18B |
| Mirum Pharmaceuticals | 6.14B |
| Veradermics | 5.47B |
| PTC Therapeutics | 5.30B |
| Scholar Rock Holding | 5.27B |
| Dianthus Therapeutics | 5.17B |
| Edgewise Therapeutics | 5.03B |